SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950135-02-002064
Filing Date
2002-04-22
Accepted
2002-04-22 00:00:00
Documents
1
Period of Report
2002-05-22

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b42687dfdef14a.txt DEF 14A 64867
  Complete submission text file 0000950135-02-002064.txt   66343
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-29089 | Film No.: 02616616
SIC: 2836 Biological Products, (No Diagnostic Substances)